ArticleTropical animal health and production2024
Growth, physiological responses, and meat quality of feedlot-finished Bonsmara steers offered unprocessed Mucuna pruriens utilis seed meal with or without conventional and green zinc oxide nanoparticles.
Article in Tropical animal health and production, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Feedlot finishing of beef cattle on commercial nutrient-dense diets based on expensive corn (maize), soybean meal (SBM) and other commonly used protein-rich ingredients is economically unsustainable, especially for smallholder farmers. Rich in energy and proteins, Mucuna pruriens utilis seed meal (MSM) could replace corn and protein-rich ingredients in beef cattle diets provided its problems of antinutritional factors (ANFs) and high fiber content that compromise animal growth performance are resolved. The objective of this study was, therefore, to investigate the effects of incorporation of conventional (C-Nano-ZnO) versus green (G-Nano-ZnO) zinc oxide (ZnO) nanoparticles in the diets of feedlot-finished Bonsmara steers supplemented with 20% MSM (dry matter basis). In a completely randomized design, 28 Bonsmara steers were randomly allocated to 4 experimental diets [i.e., Control diet without MSM (C); C with 20% MSM replacing corn (partially) and the common protein-rich ingredients (CM); CM with 25 mg/kg C-Nano-ZnO (CM-C); and CM with 25 mg/kg G-Nano-ZnO (CM-G)] each with seven replicates for 98 days. Performance variables, carcass traits, hemato-biochemistry, and meat quality were then measured. All data were analyzed with SAS using one-way ANOVA applying the GLM procedure, with diet as the independent variable, except for growth performance data that were analyzed as repeated measures. Results showed that while dietary MSM did not affect (P > 0.05) meat quality and serum biochemistry, it decreased body weight gain (BWG; P < 0.01), feed intake (FI; P = 0.001), feed conversion efficiency (FCE; P < 0.01), carcass fatness (P = 0.05), hot carcass weight (HCW; P < 0.05), cold carcass weight (CCW; P = 0.05), blood MCV (P < 0.05), MCH (P < 0.01), and neutrophils (P < 0.01) as it increased blood lymphocytes (P < 0.001). Interestingly, the harmful effects of MSM were attenuated by C-Nano-ZnO and worsened by G-Nano-ZnO. In conclusion, feeding of high dietary unprocessed MSM did not affect Bonsmara beef meat quality and serum biochemistry but compromised their growth performance, carcass traits, and some hematology responses, and these were alleviated by C-Nano-ZnO and deteriorated by G-Nano-ZnO incorporation. We recommend feeding commercial diets supplemented with 20% MSM, replacing corn and commonly used protein-rich ingredients, plus 25 mg/kg of C-Nano-ZnO to feedlot-finishing beef cattle.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.